LERClass II
Fluorescent Immunoassay, Theophylline
21 CFR 862.3880 / Clinical Toxicology
LER is the FDA product code for Fluorescent Immunoassay, Theophylline, a class II device type, regulated under 21 CFR 862.3880. As of , FDA records hold 15 510(k) clearances under this code, the most recent dated , and one recall.
Classification record
- Product code
- LER
- Device name
- Fluorescent Immunoassay, Theophylline
- Regulation
- 21 CFR 862.3880
- Device class
- Class II
- Review panel
- Clinical Toxicology
- Submission type
- 510(k)
- Implant
- No
- Life sustaining or supporting
- No
- GMP exempt
- No
- Third party review eligible
- Yes
- Ingested clearances
- 15
- Ingested recalls
- 1
Clearances, product code LER
By decision yearShow the numbers
| Year | Clearances |
|---|---|
| 1981 | 4 |
| 1982 | 1 |
| 1983 | 3 |
| 1984 | 2 |
| 1986 | 2 |
| 1988 | 1 |
| 1990 | 1 |
| 1994 | 1 |
Applicants with the most clearances
Product code LER| Applicant | Clearances |
|---|---|
| Miles Laboratories, Inc. | 3 |
| 3M Company | 1 |
| Abbott Medical | 1 |
| American Diagnostic Corp. | 1 |
| Bio-Rad | 1 |
| Hoffmann-La Roche, Inc. | 1 |
| Microgenics Corporation | 1 |
| Paragon Diagnostics, Inc. | 1 |
| Sclavo, Inc. | 1 |
| Sigma Diagnostics, Inc. | 1 |
Companies listing this code with FDA
Companies whose registered establishments list this codeNo registered establishment in MDM’s records lists product code LER.
FIRST ARTICLE / WEEKLY
What cleared, what was recalled, and what changed in the standards. One edition a week for the people who make medical devices.
